Motevalli, M. H., Taheri, S., Peiravian, F., & Yousefi, N. (2019). Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review. International Pharmacy Acta, 2(1), 2e10:1–6. https://doi.org/10.22037/ipa.v2i1.24856